SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-005060
Filing Date
2024-04-15
Accepted
2024-04-15 07:30:12
Documents
15
Period of Report
2024-04-15
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bpth-20240415x8k.htm   iXBRL 8-K 38982
2 EX-99.1 bpth-20240415xex99d1.htm EX-99.1 17903
3 GRAPHIC bpth-20240415xex99d1001.jpg GRAPHIC 10795
  Complete submission text file 0001558370-24-005060.txt   196863

Data Files

Seq Description Document Type Size
4 EX-101.SCH bpth-20240415.xsd EX-101.SCH 3153
5 EX-101.LAB bpth-20240415_lab.xml EX-101.LAB 15926
6 EX-101.PRE bpth-20240415_pre.xml EX-101.PRE 10126
18 EXTRACTED XBRL INSTANCE DOCUMENT bpth-20240415x8k_htm.xml XML 4867
Mailing Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401
Business Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401 (832) 742-1357
BIO-PATH HOLDINGS, INC. (Filer) CIK: 0001133818 (see all company filings)

IRS No.: 870652870 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36333 | Film No.: 24843105
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)